Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

Contributed by: Business Wire

Logo

Tags

FDA

Pharmaceutical

Managed Care

Oncology

General Health

Mental Health

Infectious Diseases

Neurology

Genetics

Clinical Trials

Cardiology

Biotechnology

Science

Other Science

Research

Health

Second Quarter 2024 Financial Results

More Like This

Prothena Reports First Quarter 2024 Financial Results and Business Highlights

Prothena Reports Third Quarter 2023 Financial Results and Business Highlights

Prothena Reports Third Quarter 2024 Financial Results and Business Highlights

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights

Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights

Prothena Reports First Quarter 2025 Financial Results and Business Highlights

Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs

Prothena to Report Second Quarter 2024 Financial Results on August 8